Patents Assigned to Soft Gel Technologies, Inc.
  • Solubilized CoQ-10
    Patent number: 10314793
    Abstract: The present invention is directed to compositions and methods of delivery of CoQ-10 solubilized in monoterpenes. Use of monoterpenes as dissolving agents, greatly effects the ability to incorporate greater amounts of bioactive CoQ-10 in formulations, such as soft gel capsules.
    Type: Grant
    Filed: August 5, 2016
    Date of Patent: June 11, 2019
    Assignee: Soft Gel Technologies, Inc.
    Inventor: Michael Fantuzzi
  • Ubiquinol and alpha lipoic acid compositions
    Patent number: 9889096
    Abstract: The present invention is directed to compositions and methods of delivery of CoQ that is reduced in the presence of lipoic acid and, optionally a fatty acid and/or optionally in a monoterpene. The compositions that include the reduced CoQ can be formulated in soft gel capsules.
    Type: Grant
    Filed: May 20, 2016
    Date of Patent: February 13, 2018
    Assignee: Soft Gel Technologies, Inc.
    Inventor: Michael Fantuzzi
  • Ubiquinol and alpha lipoic acid compositions
    Patent number: 9345672
    Abstract: The present invention is directed to compositions and methods of delivery of CoQ that is reduced in the presence of lipoic acid and, optionally a fatty acid and/or optionally in a monoterpene. The compositions that include the reduced CoQ can be formulated in soft gel capsules.
    Type: Grant
    Filed: June 30, 2014
    Date of Patent: May 24, 2016
    Assignee: Soft Gel Technologies, Inc.
    Inventor: Michael Fantuzzi
  • Solubilized CoQ-10
    Patent number: 8932585
    Abstract: The present invention is directed to compositions and methods of delivery of CoQ-10 solubilized in monoterpenes. Use of monoterpenes as dissolving agents, greatly effects the ability to incorporate greater amounts of bioactive CoQ-10 in formulations, such as soft gel capsules.
    Type: Grant
    Filed: January 27, 2014
    Date of Patent: January 13, 2015
    Assignee: Soft Gel Technologies, Inc.
    Inventor: Michael Fantuzzi
  • Solubilized CoQ-10
    Patent number: 8932584
    Abstract: The present invention is directed to compositions and methods of delivery of CoQ-10 solubilized in monoterpenes. Use of monoterpenes as dissolving agents, greatly effects the ability to incorporate greater amounts of bioactive CoQ-10 in formulations, such as soft gel capsules.
    Type: Grant
    Filed: December 27, 2013
    Date of Patent: January 13, 2015
    Assignee: Soft Gel Technologies, Inc.
    Inventor: Michael Fantuzzi
  • Method of making a soft gel capsule comprising CoQ-10 solubilized in a monoterpene
    Patent number: 8865032
    Abstract: The present invention is directed to compositions and methods of delivery of CoQ-10 solubilized in monoterpenes. Use of monoterpenes as dissolving agents, greatly effects the ability to incorporate greater amounts of bioactive CoQ-10 in formulations, such as soft gel capsules.
    Type: Grant
    Filed: August 13, 2013
    Date of Patent: October 21, 2014
    Assignee: Soft Gel Technologies, Inc.
    Inventor: Michael Fantuzzi
  • Ubiquinol and alpha lipoic acid compositions
    Patent number: 8821925
    Abstract: The present invention is directed to compositions and methods of delivery of CoQ that is reduced in the presence of lipoic acid and, optionally a fatty acid and/or optionally in a monoterpene. The compositions that include the reduced CoQ can be formulated in soft gel capsules.
    Type: Grant
    Filed: December 31, 2012
    Date of Patent: September 2, 2014
    Assignee: Soft Gel Technologies, Inc.
    Inventor: Michael Fantuzzi
  • Solubilized CoQ-10
    Publication number: 20140140974
    Abstract: The present invention is directed to compositions and methods of delivery of CoQ-10 solubilized in monoterpenes. Use of monoterpenes as dissolving agents, greatly effects the ability to incorporate greater amounts of bioactive CoQ-10 in formulations, such as soft gel capsules.
    Type: Application
    Filed: January 27, 2014
    Publication date: May 22, 2014
    Applicant: Soft Gel Technologies, Inc.
    Inventor: Michael Fantuzzi
  • Solubilized CoQ-10
    Publication number: 20140112900
    Abstract: The present invention is directed to compositions and methods of delivery of CoQ-10 solubilized in monoterpenes. Use of monoterpenes as dissolving agents, greatly effects the ability to incorporate greater amounts of bioactive CoQ-10 in formulations, such as soft gel capsules.
    Type: Application
    Filed: December 27, 2013
    Publication date: April 24, 2014
    Applicant: Soft Gel Technologies, Inc.
    Inventor: Michael Fantuzzi
  • Solubilized CoQ-10
    Patent number: 8658161
    Abstract: The present invention is directed to compositions and methods of delivery of CoQ-10 solubilized in monoterpenes. Use of monoterpenes as dissolving agents, greatly effects the ability to incorporate greater amounts of bioactive CoQ-10 in formulations, such as soft gel capsules.
    Type: Grant
    Filed: January 24, 2012
    Date of Patent: February 25, 2014
    Assignee: Soft Gel Technologies, Inc.
    Inventor: Michael Fantuzzi
  • Solubilized CoQ-10
    Patent number: 8617541
    Abstract: The present invention is directed to compositions and methods of delivery of CoQ-10 solubilized in monoterpenes. Use of monoterpenes as dissolving agents, greatly effects the ability to incorporate greater amounts of bioactive CoQ-10 in formulations, such as soft gel capsules.
    Type: Grant
    Filed: February 2, 2012
    Date of Patent: December 31, 2013
    Assignee: Soft Gel Technologies, Inc.
    Inventor: Michael Fantuzzi
  • Method of Making a Soft Gel Capsule Comprising CoQ-10 Solubilized in a Monoterpene
    Publication number: 20130330405
    Abstract: The present invention is directed to compositions and methods of delivery of CoQ-10 solubilized in monoterpenes. Use of monoterpenes as dissolving agents, greatly effects the ability to incorporate greater amounts of bioactive CoQ-10 in formulations, such as soft gel capsules.
    Type: Application
    Filed: August 13, 2013
    Publication date: December 12, 2013
    Applicant: Soft Gel Technologies, Inc.
    Inventor: Michael Fantuzzi
  • Hyaluronic acid in soft gel form
    Patent number: 8551975
    Abstract: An orally administered soft gelatin formulation preparation of low molecular weight Hyaluronic Acid (HA) for use as a nutritional supplement to provide the primary benefit of internally causing the softening of the human skin.
    Type: Grant
    Filed: October 10, 2006
    Date of Patent: October 8, 2013
    Assignee: Soft Gel Technologies, Inc.
    Inventors: Ronald G. Udell, Yousry M. A. Naguib
  • Coenzyme Q10 formulation and process methodology for soft gel capsules manufacturing
    Patent number: 8506995
    Abstract: A formulation of Coenzyme Q10, beta-carotenes, Vitamin E, and medium chain triglycerides in rice bran oil and an optional thickener, such as bee's wax, is provided in a soft gel capsule so that a maximum of the Coenzyme Q10 is absorbed by the human body. Generally, about 60 mg of Coenzyme Q10 is the normal amount provided daily to a healthy sedentary adult.
    Type: Grant
    Filed: July 19, 2007
    Date of Patent: August 13, 2013
    Assignee: Soft Gel Technologies, Inc.
    Inventor: Ronald G. Udell
  • Method of making a soft gel capsule comprising CoQ-10 solubilized in a monoterpene
    Patent number: 8506859
    Abstract: The present invention is directed to compositions and methods of delivery of CoQ-10 solubilized in monoterpenes. Use of monoterpenes as dissolving agents, greatly effects the ability to incorporate greater amounts of bioactive CoQ-10 in formulations, such as soft gel capsules.
    Type: Grant
    Filed: February 28, 2012
    Date of Patent: August 13, 2013
    Assignee: Soft Gel Technologies, Inc.
    Inventor: Michael Fantuzzi
  • Ubiquinol and Alpha Lipoic Acid Compositions
    Publication number: 20130129821
    Abstract: The present invention is directed to compositions and methods of delivery of CoQ that is reduced in the presence of lipoic acid and, optionally a fatty acid and/or optionally in a monoterpene. The compositions that include the reduced CoQ can be formulated in soft gel capsules.
    Type: Application
    Filed: December 31, 2012
    Publication date: May 23, 2013
    Applicant: Soft Gel Technologies, Inc.
    Inventor: Soft Gel Technologies, Inc.
  • Ubiquinol and alpha lipoic acid compositions
    Patent number: 8343541
    Abstract: The present invention is directed to compositions and methods of delivery of CoQ that is reduced in the presence of lipoic acid and, optionally a fatty acid and/or optionally in a monoterpene. The compositions that include the reduced CoQ can be formulated in soft gel capsules.
    Type: Grant
    Filed: March 14, 2008
    Date of Patent: January 1, 2013
    Assignee: Soft Gel Technologies, Inc.
    Inventor: Michael Fantuzzi
  • Method of Making a Soft Gel Capsule Comprising CoQ-10 Solubilized in a Monoterpene
    Publication number: 20120153519
    Abstract: The present invention is directed to compositions and methods of delivery of CoQ-10 solubilized in monoterpenes. Use of monoterpenes as dissolving agents, greatly effects the ability to incorporate greater amounts of bioactive CoQ-10 in formulations, such as soft gel capsules.
    Type: Application
    Filed: February 28, 2012
    Publication date: June 21, 2012
    Applicant: Soft Gel Technologies, Inc.
    Inventor: Michael Fantuzzi
  • Solubilized CoQ-10
    Publication number: 20120128769
    Abstract: The present invention is directed to compositions and methods of delivery of CoQ-10 solubilized in monoterpenes. Use of monoterpenes as dissolving agents, greatly effects the ability to incorporate greater amounts of bioactive CoQ-10 in formulations, such as soft gel capsules.
    Type: Application
    Filed: February 2, 2012
    Publication date: May 24, 2012
    Applicant: Soft Gel Technologies, Inc.
    Inventor: Michael Fantuzzi
  • Solubilized CoQ-10
    Publication number: 20120121566
    Abstract: The present invention is directed to compositions and methods of delivery of CoQ-10 solubilized in monoterpenes. Use of monoterpenes as dissolving agents, greatly effects the ability to incorporate greater amounts of bioactive CoQ-10 in formulations, such as soft gel capsules.
    Type: Application
    Filed: January 24, 2012
    Publication date: May 17, 2012
    Applicant: Soft Gel Technologies, Inc.
    Inventor: Michael Fantuzzi